Market Update: AbbVie Inc (NYSE:ABBV) – Infinity And AbbVie Announce Global Strategic Collaboration To Develop And Commercialize Duvelisib (IPI-145) In Oncology

[PR Newswire] – CAMBRIDGE, Mass. and NORTH CHICAGO, Ill., Sept. 3, 2014 /PRNewswire/ — Infinity Pharmaceuticals, Inc. (INFI) and AbbVie Inc. (ABBV) today announced that they have entered into a global collaboration to . . . → Read More: Market Update: AbbVie Inc (NYSE:ABBV) – Infinity And AbbVie Announce Global Strategic Collaboration To Develop And Commercialize Duvelisib (IPI-145) In Oncology Similar Articles: Stock Update (NYSE:ABBV): AbbVie Cystic Fibrosis Scholarship Program Awards 40 Student Scholars With Annual Academic Awards Stock Update (NYSE:ABBV): INVESTOR ALERT: Investigation of AbbVie Inc. Announced by The Wagner Firm Stock market seasonality mid-year update